HSBC HOLDINGS PLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 873630 LONDON, X0

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,278,595

+$1,588,026 QoQ

Shares Held

20,539

+143.5% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#148

of 462 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $318,191,174 across 30 Drug Manufacturers - Specialty & Generic names. LNTH ranks #8 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,839,811	$132,208,811
2	UTHR	UNITED THERAPEUTICS Corp	127,125	$68,880,136
3	TEVA	Teva Pharmaceutical Industries Ltd	785,524	$26,613,551
4	VTRS	Viatris Inc	1,518,578	$24,115,016
5	HIMS	Hims & Hers Health, Inc.	632,408	$21,925,584
6	NBIX	Neurocrine Biosciences Inc	115,990	$19,548,952
7	LQDA	Liquidia Corp	117,620	$9,377,842
8	LNTH	Lantheus Holdings, Inc. This page	20,539	$2,278,595

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,278,595	20,539	+143.5%	Shares	Defined	2026-08-14
2025-06-30	$690,569	8,436	+247.0%	Shares	Sole	2025-08-13
2025-03-31	$237,265	2,431	-91.1%	Shares	Defined	2025-05-14
2023-06-30	$2,282,371	27,197	+981.0%	Shares	Defined	2023-08-11
2023-03-31	$207,720	2,516	-95.1%	Shares	Sole	2023-05-15
2022-12-31	$2,591,519	50,854	+289.3%	Shares	Defined	2023-02-14
2022-09-30	$918,720	13,063	-28.4%	Shares	Defined	2022-11-14
2022-06-30	$1,204,519	18,242	-8.2%	Shares	Defined	2022-08-11
2022-03-31	$1,099,286	19,875	+63.7%	Shares	Defined	2022-05-16
2021-12-31	$350,695	12,139	+39.2%	Shares	Defined	2022-02-11
2021-09-30	$224,006	8,723	-9.7%	Shares	Defined	2021-11-12
2021-06-30	$266,974	9,659	—	Shares	Defined	2021-08-13
No filing history on record for this holder in this stock.